ORBIMED ADVISORS LLC reported 5 transactions at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/5/2024ACC: 0000947871-24-000353
Director10% Owner
Since Dec 2020
-8.01M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
8.01M disposed
Non-Derivative Transactions5
Common Stock
Indirect
Shares
−1.37M
Price / share
—
Trade value
—
% of position
New position
4/3/2024
1.37M→0.00
Common Stock
Indirect
Shares
−4.74M
Price / share
—
Trade value
—
% of position
New position
4/3/2024
4.74M→0.00
Common Stock
Indirect
Shares
−1.37M
Price / share
—
Trade value
—
% of position
New position
4/3/2024
1.37M→0.00
Common Stock
Indirect
Shares
−84.60K
Price / share
—
Trade value
—
% of position
New position
4/3/2024
84.60K→0.00
Common Stock
Indirect
Shares
−450K
Price / share
—
Trade value
—
% of position
New position
4/3/2024
450K→0.00
Total
Net shares
−8.01M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/3/2024 | D · Disposition | −1.37M | — | — | New position | 1.37M | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −4.74M | — | — | New position | 4.74M | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −1.37M | — | — | New position | 1.37M | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −84.60K | — | — | New position | 84.60K | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −450K | — | — | New position | 450K | 0.00 |
| Total | −8.01M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported